ANTI CRAVING MEDICATIONS. Marla D. Kushner, DO, FACOFP, FASAMd, FSAHM
|
|
- Dorthy Logan
- 7 years ago
- Views:
Transcription
1 ANTI CRAVING MEDICATIONS Marla D. Kushner, DO, FACOFP, FASAMd, FSAHM 1
2 VIVITROL NALTREXONE FOR EXTENDED RELEASE INJECTABLE SUSPENSION (LONG ACTING SHOT) 2
3 Relevant drugs: Opiates, heroin, alcohol How it works: Vivitrol is a competitive opioid antagonist. This means that it occupies the sites in the brain that opioids and alcohol normally bind to. With Vivitrol, there are no more available spaces for additional opiates or alcohol to bind to. This results in the other drugs inability to produce their effects, including euphoria. Even though Vivitrol may block the intense high from opioids, it does not prevent good feelings that come from other naturally pleasurable activities, i.e. only subsets of opiate receptors are blocked, thus allowing natural opiate receptors to bind, for example, endorphins from exercise. 3
4 Vivitrol: Who can take it? They must meet the following Criteria: -Have not taken any opiates/heroin for at least 7-10 days -Are not actively drinking at time of initiation -Are able to not drink alcohol in an out-patient setting (not under continuous supervision) -Are able to follow-up each month before medication effects expire.
5
6 Benefits of Vivitrol: Patients will not get high or drunk even if they use and drink. This decreases the temptation of relapse. There is no need to remember to take a medication daily. There is no need to keep medication in the house. This means it will not be lost or stolen. Dosing is standardized 380 mg each month. The medical professional administering the shot witnesses the dosing. Vivitrol is an injection that slowly releases over one month. Thus you do not have to remember to take a pill, or worry about how your body metabolizes the medication (i.e. in cases of liver damage).
7 Drawbacks of Vivitrol: It is expensive. Insurance can help ($1, manufacturer s price). It is essential to receive each shot within 1 month or a few days less than 1 month of the previous shot. Side effects are uncommon but possible: liver damage, depression, suicidality, nausea/vomiting/ diarrhea, allergic reaction, muscle soreness at site of injection. Vivitrol treats the physical dependence on opioids and alcohol, but further psychosocial interventions (such as counseling and group therapy) are often required to enable people to maintain abstinence.
8 DANGER: While on Revia or Vivitrol, patients become opiate naïve. This means that their bodies can no longer handle the amount of opiates that they may have been used to before. Therefore, if a patient who has been taking ReVia or Vivitrol relapses, it is easy to overwhelm the body s ability to handle the opiates and overdose and death are more likely.
9 REVIA Generic: naltrexone hydrochloride (pill)
10
11 Relevant drugs: Opiates, heroin, alcohol
12 How it works: ReVia and Vivitrol are different forms of naltrexone but, whereas Vivitrol is the longacting shot form, ReVia is the short-acting pill form. Like Vivitrol, it occupies the sites in the brain that opiates, heroin, and alcohol act on. This prevents these drugs from producing a high, buzz, or euphoria.
13 Who can take it? Patients seeking medical assistance during recovery of addiction may take ReVia if they meet the following criteria: -Have not taken any opiates/heroin for at least 7-10 days -Are not actively drinking at time of initiation -Are able to not drink alcohol in an out-patient setting (not under continuous supervision) -Are reliable to commit to taking the pill every day and will not skip doses either intentionally or unintentionally
14 Benefits of ReVia: Patients will not get high or drunk even if they use and drink. This decreases the temptation of relapse. The medication s potency is consistent over the course of a month, as opposed to Vivitrol. No shot is required so side effects like muscle soreness and a lump at the site of injection are not an issue. It is relatively inexpensive ($ manufacturer s price for 30 pills).
15 Drawbacks of ReVia: The patient must be willing and able to take the pill every day. There is a possibility of the pills getting lost or stolen. Side effects are possible. Nausea is the most common one and can be decreased by taking the pill with food. Other side effects: liver damage, diarrhea, depression/suicidality, allergic reaction
16 Other facts about Revia: It will NOT make you high or give you a sense of euphoria. It will NOT make you sick if you use/drink while on it. It is NOT addictive.
17 *As with all anti-craving medications, ReVia is meant to be used alongside psychological and social recovery measures. It is not meant to be used alone for recovery.
18 CAMPRAL Generic: acamprosate (pill)
19 Relevant drug: Alcohol
20 How it works: The way that Campral works is not completely understood. It is a GABA agonist and a glutamate antagonist which means that it effects chemicals in the brain related to alcohol use. By interfering with glutamate s ability to bind in the brain and enhancing GABA activity in the brain, Campral is somehow able to bring a chemical balance to the brain which decreases alcohol cravings.
21
22 Who can take it? Patients seeking medical assistance during recovery from alcohol may be candidates for Campral if s/he has stopped drinking alcohol and is finished with withdrawal. It is recommended to start Campral as soon as a patient is finished with withdrawal. If a patient relapses, it is recommended to continue the medication.
23
24 Benefits of Campral: It has been shown to decrease cravings for alcohol in people recovering from alcohol abuse. It will NOT make a patient sick if s/he drinks while taking the medication. This makes some patients more likely to take the medication everyday. It is considered safe and will not endanger the patient s life if a relapse occurs while on medication.
25 Drawbacks of Campral: A patient must have already gone through withdrawal before s/he can begin taking Campral. It becomes less and less effective if a patient continues to drink while taking the medication. Standard dosing is 2 pills taken 3 times each day for a total of 6 pills daily. It can be difficult to remember to take the medication on schedule. Can be expensive ($500 - $550 manufacturer s price for standard 1-month supply). Insurance can help. Side effects are possible. Diarrhea is the most common one.
26 Buprenorphine and naloxone (film or tablet)
27 Relevant drugs: Heroin, opiates
28 How it works: Buprenorphine is available as a pill and as a film that dissolves under the tongue. It is a combination of 2 different medicines buprenorphine and naloxone. Buprenorphine is a partial opioid agonist. This means that it acts in the same sites of the brain as opiates but does not have the full effects that opiates do. This minimizes withdrawal symptoms and cravings. Naloxone is a strong opioid antagonist. This means that it occupies the same sites in the brain that opiates do, leaving no open spaces for them to bind to. In this way, buprenorphine allows some stimulation of the opiate areas of the brain but in a controlled, plateaued manner.
29 Beginning Buprenorphine Induction: Before a patient can begin Buprenorphine, they must have already begun withdrawal. They can then come to the office where they will receive a urine drug screen because if certain drugs, like benzodiazepines, are in the patient s system, a life-threatening drug interaction can occur. If it is confirmed that the patient is in withdrawal and the urine drug screen results are okay then the patient will be given a prescription for a mild dose of Buprenorphine.
30 In My Practice: The patient will get the prescription filled and immediately return to the office to take the first dose under physician supervision. Half an hour later, they can take the second dose under physician supervision. At that time, the physician will create a gradually increasing dosing plan for the patient to follow until a follow-up visit 2-3 days later. At the follow-up visit, a more consistent dose will be planned. Until the patient s ideal buprenorphine dose is discovered, frequent follow-up appointments and smaller prescription quantities are necessary.
31
32 Benefits of Buprenorphine: It minimizes cravings and withdrawal symptoms in patients recovering from addiction. Patients who have been addicted to heroin and/or opiates in the past will NOT get high from Buprenorphine and will have difficulty getting high from heroin/opiates while on Buprenorphine. It can be taken orally and does not require going to a special clinic for each dose.
33 Drawbacks of Buprenorphine: Patients become physically and psychologically dependent on buprenorphine successfully stopping Buprenorphine usually requires the assistance of a professional facility/hospital. Buprenorphine is a long-term medication and patients should not start it planning to stop taking it any time soon. Dosing can be tricky. Patient s must follow-up often with a physician who is experienced with buprenorphine and patients should never change their dose without talking to their physician first.
34 Stigma lots of people do not understand Buprenorphine and have misinformed ideas about how the medication works. Can be expensive pricing varies depending on dosage and form. Insurance and coupons can help. Side effects are possible most common ones include headache, pain, and withdrawal symptoms. These can be minimized with physician-guided dosing adjustments.!
35 CHANTIX Generic: Varenicline
36 Relevant Drug: Cigarettes/Nicoti ne
37 How it Works: Chantix is a non-nicotine containing prescription medicine. It is a partial nicotine agonist, thus it works in two ways. It targets nicotine receptors in the brain, attaches to them, and blocks nicotine from reaching them. It is believed that Chantix also activates these receptors, causing a reduced release of dopamine compared to nicotine. Usually Chantix is used for 12 weeks and cravings and smoking cessation status is reassessed. An additional 12 weeks may be appropriate if patient is still smoking or having cravings for cigarettes.
38 Who can take it? Anyone over the age of 18 who is considering quitting smoking. Those currently in pharmacologically managed opiate addiction. Research suggests that simultaneously treating nicotine addiction improves outcomes of opiate addiction. Smoking prevalence rates of 80% 95% among opiate addiction
39 Benefits of Chantix In one study quit rates were 56.4% compared to 11.6% in a placebo group Decreases physical cravings for nicotine Failure to address tobacco use may negatively affect pharmacologically managed opioid discontinuation (ie Naltrexone and Suboxone therapy). Opioid detoxification may offer a window of opportunity to expand smoking cessation treatment, hence improving opiate addiction outcomes. Cost effective, and significantly cheaper than smoking in the long term. Behavioral counseling and pharmacotherapy show to be the most successful steps to quit smoking.
40 Disadvantages of Chantix Abnormal dreams and nightmares, tiredness or insomnia and headaches GI side effects (nausea, vomiting, constipation, gas) Rash, shortness of breath of dry mouth Pregnancy category C (may be harmful to fetus but benefits may outweigh the risks)
41 Special tips for Chantix Set a Quit date and begin Chantix one week before quitting Take with full glass of water Do not deviate from dosage instructions as side effects may be more severe
42 Other Methods for assisting with smoking cessation Incorporating behavioral therapy and counseling Nicotine replacement such as patches, gum, lozenges Buproprion Clonidine
43 Thank You!
Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
More informationMedications Used in the Treatment of Addiction Developed by Randall Webber, MPH. Alcohol Withdrawal
Medications Used in the Treatment of Addiction Developed by Randall Webber, MPH Alcohol Withdrawal MEDICATION Long/intermediateacting benzodiazepines (e.g., chlordiazepoxide/ Librium, diazepam/valium)
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationUse of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationIt is important that you tell your family and the people closest to you of this increased sensitivity to opioids and the risk of overdose.
MEDICATION GUIDE VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection.
More informationThe Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationOpioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
More informationMedication Assisted Treatment of Substance Use Disorders
Medication Assisted Treatment of Substance Use Disorders April 8, 2015 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary Care
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationSubstance Abuse Treatment. Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence
Spring 2007 Volume 6 Issue 1 ADVISORY News for the Treatment Field Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence What is naltrexone for extendedrelease injectable
More informationNaltrexone and Alcoholism Treatment Test
Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: PDP IBT Inj - Vivitrol Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Opiate Antagonist Client: 2007 PDP IBT Inj Approval Date: 2/20/2007
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationAdjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.
Shared Care Guideline for Prescription and monitoring of Naltrexone Hydrochloride in alcohol dependence Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist,
More informationBuprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationReintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience
Reintegration Recovery Medication-Assisted Treatment for Alcohol Dependence Reintegration Resilience 02 How do you free yourself from the stress and risks of alcohol dependence? Most people cannot do it
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationUse of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationMedicines To Treat Alcohol Use Disorder A Review of the Research for Adults
Medicines To Treat Alcohol Use Disorder A Review of the Research for Adults Is This Information Right for Me? Yes, this information is right for you if: Your doctor* said you have alcohol use disorder
More informationShare the important information in this Medication Guide with members of your household.
MEDICATION GUIDE BUPRENORPHINE (BUE-pre-NOR-feen) Sublingual Tablets, CIII IMPORTANT: Keep buprenorphine sublingual tablets in a secure place away from children. Accidental use by a child is a medical
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationOpioids and Medications to Treat Opioid Dependence
Opioids and Medications to Treat Opioid Dependence Colleen T. LaBelle BSN, RN-BC, CARN Program Director STATE OBOT B Boston University School of Medicine Boston Medical Center Colleen T LaBelle, RN, CARN
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationUnderstanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders
Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationthe facts about NALTREXONE
the facts about NALTREXONE for Treatment of Opioid Addiction It s not like I woke up one day when I was young and told myself, I wanna be a drug addict. I wanna ruin my life and ruin the lives of those
More informationCo-morbid physical disorders e.g. HIV, hepatitis C, diabetes, hypertension. Medical students will gain knowledge in
1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage withdrawal during detoxification, stabilisation and substitution as well as for relapse prevention,
More information1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
More informationA prisoners guide to buprenorphine
A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationHulpverleningsmodellen bij opiaatverslaving. Frieda Matthys 6 juni 2013
Hulpverleningsmodellen bij opiaatverslaving Frieda Matthys 6 juni 2013 Prevalence The average prevalence of problem opioid use among adults (15 64) is estimated at 0.41%, the equivalent of 1.4 million
More informationMethamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.
Methamphetamine Introduction Methamphetamine is a very addictive stimulant drug. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationUse of Buprenorphine in the Treatment of Opioid Addiction
Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an
More informationConceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationOpiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
More informationIn 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
More informationFinancial Disclosures
Opioid Agonist Therapy: To Maintain or Not To Maintain - A Case Discussion PCSS-MAT American Psychiatric Association Drs. Ed Salsitz, John Renner, Timothy Fong April 14, 2015 Financial Disclosures Edwin
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationPatient Information and Consent to Treatment with Buprenorphine
1063 Lower Main St, Ste C212 JEFFREY H. CHESTER, DO Phone 808.249.8887-6006 www.ponohealthcare.com Board Certified by American Board of Physical Medicine & Rehabilitation Board Certified by American Society
More information5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationAssessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in
More informationThe CCB Science 2 Service Distance Learning Program
S2S 2055 DETOXIFICATION Module 1 Post-Test 1. A common use of a biochemical marker is. a. to support or refute other information that leads to proper diagnosis b. for forensic purposes c. in detecting
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationUCLA-SAPC Lecture Series March 13, 2015. Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control
UCLA-SAPC Lecture Series March 13, 2015 Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control Neurobiology 101 Neuroscience of Addiction & Recovery Medication-Assisted Treatment (MAT)
More informationOpioids Research to Practice
Opioids Research to Practice CRIT/FIT 2015 May 2015 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research
More informationPATHWAYS TO RECOVERY
PATHWAYS TO RECOVERY PATHWAYS TO RECOVERY When Faces & Voices of Recovery was launched in 2001, our founding goal was to celebrate and honor recovery in all of its diversity. We believe that everyone has
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationAcknowledgements: NIDA grants: R01DA 13636, 024550, 021579
Myths an nd Facts about Medication Assisted Treatment Robert P. Schwartz, M.D. Fi Friends Research Institute t Acknowledgements: NIDA grants: R01DA 13636, 024550, 021579 FDA-approved Medicatio ns: Nicotine
More informationNaltrexone for Opioid & Alcohol Use Disorders
Naltrexone for Opioid & Alcohol Use Disorders Reid K. Hester, Ph.D. Director, Research Division Behavior Therapy Associates, LLC Senior Science Advisor Checkup and Choices, LLC 505.345.6100 reidkhester@gmail.com
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationSmoking Cessation. 45 Million americans smoke 35 Million want to quit smoking
45 Million americans smoke 35 Million want to quit smoking It's not hard to quit smoking, I've quit thousands of times. Mark Twain Why are people addicted to cigarettes? Nicotine Nicotine is a naturally
More informationHeroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
More informationMEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)
MEDICATION GUIDE SUBOXONE (Sub-OX-own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII) IMPORTANT: Keep SUBOXONE in a secure place away from children. Accidental
More informationOTC Abuse. Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University
OTC Abuse Dr. Eman Said Abd-Elkhalek Lecturer of Pharmacology & Toxicology Faculty of Pharmacy Mansoura University Opiates Abuse Opioids are a group of natural, partially synthetic, or synthetic drugs
More informationNaltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance
Naltrexone Shared Care Guideline for the treatment of alcohol dependence and opioid dependance Introduction Indication/Licensing information: Naltrexone is licensed for use as an additional therapy, within
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationTobacco Addiction. Presented by: Dawn M. Dunn, M.P.H. & Dotsie Anfenson
Tobacco Addiction Presented by: Dawn M. Dunn, M.P.H. & Dotsie Anfenson Presentation Overview Tobacco Use: The Realities Nicotine Addiction Pharmacological Treatments Tobacco Use: Assessing CA s Progress
More informationThe Heroin Epidemic in Adolescents and Young Adults. Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015
The Heroin Epidemic in Adolescents and Young Adults Marla D. Kushner, DO, FACOFP, FASAM, FSAHM AOAAM February 25, 2015 1 Marla Kushner, DO, Disclosures Speaker Bureau Alkermes Reckitt Benckiser 2 TARGET
More informationLow dose naltrexone as a treatment for multiple sclerosis
Low dose naltrexone as a treatment for multiple sclerosis Can I take study demonstrated that naltrexone The low dose naltrexone as a treatment for multiple sclerosis should be of naltrexone is microcrystalline
More informationMedications for Alcohol and Opioid Use Disorders
Medications for Alcohol and Opioid Use Disorders Andrew J. Saxon, M.D. Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Health Care System Alcohol Pharmacotherapy
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationMedication-Assisted Treatment (MAT) & What It Means Long-Term Gary K. Byrd., M.Ed., MAC, CCS, CAMS Methadone is the Gold Standard for treatment of chronic heroin addiction Gary Byrd 2015 1 Gary Byrd 2015
More informationTreatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationCLINICAL POLICY Department: Medical Management Document Name: Vivitrol Reference Number: NH.PHAR.96 Effective Date: 03/12
Page: 1 of 7 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
More informationARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More informationBUPRENORPHINE. the facts about. for Treatment of Opioid Addiction
the facts about BUPRENORPHINE for Treatment of Opioid Addiction U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationOVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
More informationCocaine. Like heroin, cocaine is a drug that is illegal in some areas of the world. Cocaine is a commonly abused drug.
Cocaine Introduction Cocaine is a powerful drug that stimulates the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants
More informationThe Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence
M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen
More informationProgram Assistance Letter
Program Assistance Letter DOCUMENT NUMBER: 2004-01 DATE: December 5, 2003 DOCUMENT TITLE: Use of Buprenorphine in Health Center Substance Abuse Treatment Programs TO: All Bureau of Primary Health Care
More informationBrain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair Michael Fishman, MD Director of Young Adult Program How Addiction Takes Hold Large & rapid upsurges in dopamine
More informationAlcohol Screening and Brief Intervention
Updatedì A POCKET GUIDE FOR Alcohol Screening and Brief Intervention Updated 2005 Edition This pocket guide is condensed from the 34-page NIAAA guide, Helping Patients Who Drink Too Much: A Clinician s
More informationMEDICATIONS USED IN THE MANAGEMENT OF SUBSTANCE USE DISORDERS
MEDIATIONS USED IN THE MANAGEMENT OF SUBSTANE USE DISORDERS Opioid Agonist Therapy (OAT) for Opioid Dependence Methadone (Dolophine, Methadose) Specialty consultation advised. Titrate carefully, consider
More informationDeveloping Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse
Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationSEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2011 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationJoanna L. Starrels. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume VIII, 2003-2004. A. Study Purpose and Rationale
Outpatient Treatment of Opiate Dependence with Sublingual Buprenorphine/Naloxone versus Methadone Maintenance: a Randomized Trial of Alternative Treatments in Real Life Settings Joanna L. Starrels A. Study
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationAlcohol Use Disorders - Pharmacotherapy and Treatment
Alcohol Use Disorders - Pharmacotherapy and Treatment State of Hawai i House Health Committee 26 Aug 2008 Informational Hearing (Reps. Josh Green, M.D., and John Mizuno; hearing hosted by Rep. Mizuno)
More information